Mechanism and Clinical Importance of Respiratory Failure Induced by Anticholinesterases

1. Hrobak PK. Nerve agents: implications for anesthesia providers. AANA J 2008;76:95-7.Search in Google Scholar

2. Bailey AM, Barker SN, Baum RA, Chandler HE, Weant KA. Being prepared: Emergency treatment following a nerve agent release. Adv Emerg Nurse J 2014;36:22-33.10.1097/TME.0000000000000008Open DOISearch in Google Scholar

3. King JM, Hunter JM. Physiology of the neuromuscular junction. Br J Anaesth CEPD Reviews 2002;2(5):129-33.Search in Google Scholar

4. Komlova M, Musilek K, Dolezal M, Gunn-Moore F, Kuca K. Structure-activity relationship of quaternary acetylcholinesterase inhibitors – outlook for early myasthenia gravis treatment. Curr Med Chem 2010;17:1810-24.10.2174/092986710791111198Open DOISearch in Google Scholar

5. Kraus CL, Trivedi RH, Wilson ME. Intraocular pressure control with echothiophate iodide in children’s eyes with glaucoma after cataract extraction. J AAPOS 2015;19:116-8.10.1016/j.jaapos.2014.11.006Search in Google Scholar

6. Watkins JW, Schwarz ES, Arroyo-Plasencia AM, Mullins ME, Toxicology Investigators Consortium Investigators. The use of physostigmine by toxicologists in anticholinergic toxicity. J Med Toxicol 2015;11:179-84.10.1007/s13181-014-0452-xSearch in Google Scholar

7. Houze P, Pronzola L, Kayouka M, Villa A, Debray M, Baud FJ. Ventilatory effects of low-dose paraoxon result from central muscarinic effects. Toxicol Appl Pharmacol 2008;233:186-92.10.1016/j.taap.2008.08.006Search in Google Scholar

8. Chahal KS, Prakash A, Majeed ABA. The role of multifunctional drug therapy against carbamate induced neuronal toxicity during acute and chronic phase in rats. Environ Toxicol Pharmacol 2015;40:220-9.10.1016/j.etap.2015.06.002Search in Google Scholar

9. Albuquerque EX, Pereira EFR, Aracava Y, Fawcett WP, Oliveira M, Randall WR, Hamilton TA, Kan RK, Romano JA Jr, Adler M. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Proc Natl Acad Sci 2006;103:13220-5.10.1073/pnas.0605370103Search in Google Scholar

10. Sivilotti MLA, Bird SB, Lo JCY, Dickson EW. Multiple centrally acting antidotes protect against severe organophosphate toxicity. Acad Emerg Med 2006;13:359-64.10.1197/j.aem.2005.10.018Search in Google Scholar

11. Antonijević B, Stojiljković MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007;5:71-82.10.3121/cmr.2007.701Open DOISearch in Google Scholar

12. Franz DR, Hilaski R. Sequence of cardiorespiratory effects of soman altered by route of administration. Toxicol Lett 1990;51:221-5.10.1016/0378-4274(90)90213-6Open DOISearch in Google Scholar

13. Bajgar J. Complex view on poisoning with nerve agents and organophosphates. Acta Med (Hradec Kralove) 2005;48:3-21.10.14712/18059694.2018.23Search in Google Scholar

14. De Candole CA, Douglas WW, Evans CL, Holmes R, Spencer KEV, Torrance RW, Wilson KM. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol 1953;8:466-75.10.1111/j.1476-5381.1953.tb01350.xSearch in Google Scholar

15. Balali-Mood M, Saber H. Recent advances in the treatment of organophosphorous poisonings. Iran J Med Sci 2012;37:74-91.Search in Google Scholar

16. Amos ML, Smith ME. Effect of organophosphate administration on the expression of pro-opiomelanocortin-derived peptides in motoneurones. Neurotoxicology 1998;19:789-97.Search in Google Scholar

17. Bajgar J, Fusek J, Kassa J, Kuca K, Jun D. Chemical aspects of prophylaxis against nerve agent poisoning. Curr Med Chem 2009;16:2977-86.10.2174/092986709788803088Open DOISearch in Google Scholar

18. Bajgar J, Fusek J, Kassa J, Jun D, Kuca K, Hajek P. An attempt to assess functionally minimal acetylcholinesterase activity necessary for survival of rats intoxicated with nerve agents. Chem-Biol Interact 2008;175:281-5.10.1016/j.cbi.2008.05.015Search in Google Scholar

19. Göransson Nyberg A, Cassel GE. Dramatic increase in cerebral blood flow following soman intoxication if signs of symptoms can be seen. Adv Toxicol 2015; Article ID 935069, 9 pages, 2015. doi:10.1155/2015/935069.10.1155/2015/935069Search in Google Scholar

20. Newmark J. Therapy for nerve agent poisoning. Arch Neurol 2004;61:649-52.10.1001/archneur.61.5.649Search in Google Scholar

21. Wright PG. An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit. J Physiol 1954;126:52-70.10.1113/jphysiol.1954.sp005191Search in Google Scholar

22. Douglas WW, Matthews PBC. Acute tetraethylpyrophosphate poisoning in cats and its modification by atropine or hyoscine. J Physiol 1952;116:202-18.10.1113/jphysiol.1952.sp004700Search in Google Scholar

23. Stewart WC. The effects of sarin and atropine on the respiratory center and neuromuscular junctions of the rat. Can J Biochem Physiol 1959;37:651-60.10.1139/o59-071Search in Google Scholar

24. Bonham AC. Neurotransmitters in the CNS control of breathing. Respir Physiol 1995;101:219-30.10.1016/0034-5687(95)00045-FSearch in Google Scholar

25. Carey JL, Dunn C, Garspari RJ. Central respiratory failure during acute organophosphate poisoning. Resp Physiol Neurobiol 2013;189:4013-10.10.1016/j.resp.2013.07.022Search in Google Scholar

26. Lindsey BG, Rybak IA, Smith JC. Computational models and emergent properties of respiratory neural network. Compr Physiol 2012;2:1619-70.10.1002/cphy.c110016Search in Google Scholar

27. Bajgar J, Hajek P, Slizova D, Krs O, Fusek J, Kuca K, Jun D, Bartosova L, Blaha V. Changes of acetylcholinesterase activity in different rat brain areas following intoxication with nerve agents: biochemical and histochemical study. Chem Biol Interact 2007;5:14-21.10.1016/j.cbi.2006.10.006Search in Google Scholar

28. Chang F-C T, Foster RE, Beers ET, Rickett DL, Filbert MG. Neurophysiological concomitants of soman-induced respiratory depression in awake, behaving guinea pigs. Toxicol Appl Pharmacol 1990;102:233-50.10.1016/0041-008X(90)90023-NOpen DOISearch in Google Scholar

29. Gillis RA, Walton DP, Quest JA, Namath IJ, Hamosh P, Dretchen KL. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla. J Pharmacol Exp Ther 1988;247:765-72.Search in Google Scholar

30. Hassel B. Nicotinic mechanisms contribute to soman-induced symptoms and lethality. Neurotoxicology 2006;27:501-7.10.1016/j.neuro.2006.01.007Open DOISearch in Google Scholar

31. Chatonnet F, Boudinot E, Chatonet A, Tayse L, Daulon S, Champagnat J, Foultz AS. Respiratory survival mechanisms in acetylcholinesterase knockout mouse. Eur J Neurosci 2003;18:1419-27.10.1046/j.1460-9568.2003.02867.xSearch in Google Scholar

32. Rickett DL, Glenn JF, Beers ET. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology 1986;7:225-36.Search in Google Scholar

33. Adams GK III, Yamamura HI, O’Leary JF. Recovery of central respiratory function following anticholinesterase intoxication. Eur J Pharmacol 1976;38:101-12.10.1016/0014-2999(76)90206-5Open DOISearch in Google Scholar

34. Shih T-M, Kan RK, McDonnough JH. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem-Biol Interact 2005;157-158:293-303.10.1016/j.cbi.2005.10.04216256093Search in Google Scholar

35. Lipp JA. Effect of atropine upon the cardiovascular system during soman-induced respiratory depression. Arch Int Pharmacodyn Ther 1976;220:19-27.Search in Google Scholar

36. Johnson DD, Stewart WC. The effects of atropine, pralidoxime, and lidocaine on nerve-muscle and respiratory function in organophosphate-treated rabbits. Can J Phisiol Pharmacol 1970;48:625-30.10.1139/y70-0925479358Search in Google Scholar

37. Gupta RC, Dettbarn W-D. Potential of memantine, d-tubocurarine and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX. Neurotoxicology 1992;13:500-14.Search in Google Scholar

38. Bajgar J. Optimal choice of acetylcholine reactivators for antidotal treatment of nerve agent intoxication. Acta Med (Hradec Kralove) 2010;53:207-11.10.14712/18059694.2016.7821400978Search in Google Scholar

39. Stewart WC, Anderson EA. Effect of a cholinesterase inhibitor when injected into the medulla of the rabbit. J Pharmacol Exp Ther 1968;162:309-18.Search in Google Scholar

40. Worek F, Szinicz L. Analysis and cardiovascular and respiratory effects of various doses of soman in guinea-pigs: Efficacy of atropine treatment. Arch Int Pharmacodyn Ther 1993;325:96-112.Search in Google Scholar

41. Brown RV. The effects of intracysternal sarin and pyridine-2-aldoxime methyl methanesulphonate in anaesthetized dogs. Br J Pharmacol 1960;15:170-4.Search in Google Scholar

42. Sudvall A. Minimum concen6rations of P2S which reverse neuromuscular block. Biochem Pharmacol 1961;8:413-7.10.1016/0006-2952(61)90059-4Search in Google Scholar

43. Thompson DF, Thompson GD, Greenwood RB, Trammel HL. Thereapeutic dosing of pralidoxime chloride. Drug Intell Clin Pharm 1987;21:590-3.10.1177/1060028087021007-804Search in Google Scholar

44. Holland P, Parkes DC. Plasma concentrations of the oxime Pralidoxime Mesylate (P2S) after repeated oral and intramuscular administration. Br J Industr Med 1976;33:43-6.10.1136/oem.33.1.43Search in Google Scholar

45. Figueiredo TH, Qashu F, Apland JP, Aroniadou-Anderjaska V, Souza AP, Braga MFM. The GluK1 (GluR5) kainate alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. J Pharmacol Exp Ther 2011;336:303-12.10.1124/jpet.110.171835Search in Google Scholar

46. Chen J, Pan H, Chen C, Wu W, Iskandar K, He J, et al. (-)-Phenserine Attenuates Soman-Induced Neuropathology. PLOS ONE 2014;9(6):e99818. doi:10.1371/journal.pone.009981810.1371/journal.pone.0099818Search in Google Scholar

47. Cain DP, Raithby A, Corcoran ME. Urethane anesthesia blocks the development and emission of kindled seizures. Life Sci 1989;44:1201-6.10.1016/0024-3205(89)90315-9Open DOISearch in Google Scholar

48. Nashef L, Walker F, Allen P, Sander JWAS, Shorvon SD, Fish DR. Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry 1996;60:297-300.10.1136/jnnp.60.3.297Open DOISearch in Google Scholar

49. Alkondon M, Albuquerque EX, Pereira EF. Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices. Neurotoxicology. 2013;36:72-81.10.1016/j.neuro.2013.02.005Search in Google Scholar

50. Bach FW, Yaksh TL. Release of beta-endorphin immunoreactivity from brain by activation of a hypothalamic N-methyl-D-aspartate receptor. Neuroscience 1995;65:775-83.10.1016/0306-4522(94)00528-DSearch in Google Scholar